FTCM
OACC

Fir Tree Capital Management’s Oaktree Acquisition Corp III Life Sciences OACC Stock Holding History

Fir Tree Capital Management’s Portfolio OACC Stock Details OACC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-45,800
Closed -$458K – 46
2024
Q4 		$458K Buy
+45,800
New +$457K 0.4% 37

Other funds holding OACC

AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
BGIM
Boussard & Gavaudan Investment Management London, United Kingdom $1.06B AUM 4.58% 1-Year Est. Return
DAM
Decagon Asset Management London, United Kingdom $525M AUM 50.51% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
LA
Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return
HCI
Harraden Circle Investments New York $784M AUM 20.59% 1-Year Est. Return

Fir Tree Capital Management's OACC Position: Q1 2025 in Review

Fir Tree Capital Management sold out of Oaktree Acquisition Corp III Life Sciences (OACC) in Q1 2025, closing a stake of 45,800 shares — an estimated $458K sold.

Fir Tree Capital Management first reported a position in OACC in Q4 2024 and held it in 1 quarter. The position peaked at $458K in Q4 2024. 39 funds tracked by Wall St. Rank hold OACC as of Q1 2025.

  • Fir Tree Capital Management reported no remaining Oaktree Acquisition Corp III Life Sciences position as of Q1 2025 after selling out during the quarter.
  • Fir Tree Capital Management sold 45,800 Oaktree Acquisition Corp III Life Sciences shares in Q1 2025, an estimated $458K.
  • Fir Tree Capital Management first reported a position in Oaktree Acquisition Corp III Life Sciences in Q4 2024 and held it in 1 quarter.
  • Fir Tree Capital Management's Oaktree Acquisition Corp III Life Sciences position peaked at $458K in Q4 2024.
  • 39 funds tracked by Wall St. Rank held Oaktree Acquisition Corp III Life Sciences as of Q1 2025.

Based on Fir Tree Capital Management's 13F filing for Q1 2025, filed 15 May 2025.